[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100527802":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":37,"centralContacts":41,"locations":47,"responsibleParty":64,"collaborators":66,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":27,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":27,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":27,"overallStatus":50,"whyStopped":27,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"University Ghent","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"1: Placebo","PLACEBO_COMPARATOR","Lactose",[13,14],"Drug: Placebo","Behavioral: Resistance training",{"label":16,"type":17,"description":18,"interventionNames":19},"H1 blockade: Telfast (180mg Fexofenadine)","EXPERIMENTAL","H1: Telfast (180mg Fexofenadine)",[20,14],"Drug: H1 blockade: Telfast: 180mg Fexofenadine",[22,28,32],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Placebo","Oral placebo",[9],null,{"type":23,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"H1 blockade: Telfast: 180mg Fexofenadine","H1 blockade: oral blockade with 180mg Fexofenadine",[16],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"BEHAVIORAL","Resistance training","Resistance training: lower body exercise",[9,16],[38],{"name":39,"affiliation":5,"role":40},"Wim Derave, Professor","PRINCIPAL_INVESTIGATOR",[42],{"name":39,"role":43,"phone":44,"phoneExt":45,"email":46},"CONTACT","92646326","+32","wim.derave@ugent.be",[48],{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Department of movement and sports sciences, Ghent University, Belgium","RECRUITING","Ghent","Oost-Vlaanderen","9000","Belgium","BE",{"type":57,"coordinates":58},"Point",[59,60],3.71667,51.05,{"lat":60,"lon":59},[63],{"name":39,"role":43,"phone":44,"phoneExt":45,"email":46},{"type":65,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR",[67],{"name":68,"class":6},"Research Foundation Flanders","100527802","the-role-of-histamine-in-muscle-protein-synthesis-following-resistance-training-100527802",false,"NCT06152497","The Role of Histamine in Muscle Protein Synthesis Following Resistance Training","The Role of Histamine in Muscle Protein Synthesis Following Chronic Resistance Training","Inclusion Criteria:\n\n* Male\n* 18-45 years\n* Not to medium physically active\n\nExclusion Criteria:\n\n* Smoking\n* Chronic disease\n* High blood pressure\n* Supplement or medication intake\n* Seasonal allergies\n* Vegetarian \u002F vegan\n* Resistance trained",true,"MALE","18 Years","45 Years",{"count":81,"type":82},50,"ESTIMATED","INTERVENTIONAL",[85],"NA","Blocking histamine H1\u002FH2 receptors blunts chronic endurance training adaptations. The current study addresses the following research question: \"What is the influence of histamine H1 signaling on training adaptations following ten weeks of resistance training in human skeletal muscle.\" Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.",[88],"Histamine","2023-12-06",{"date":91,"type":92},"2023-12-13","ACTUAL",{"date":94,"type":92},"2023-09-01",{"date":96,"type":82},"2026-12-31",{"name":5,"class":6},1]